![NCCN Recommends Molecular Testing for Pediatric Cancer Treatment](https://www.g2intelligence.com/wp-content/uploads/2022/07/July20-2022.News_.PediatricCancer-iStock-1800x1250-1-1080x675.jpg)
NCCN Recommends Molecular Testing for Pediatric Cancer Treatment
The new guidelines will likely prove highly influential with oncologists and payors.
The new guidelines will likely prove highly influential with oncologists and payors.
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
Researchers propose solutions to underrepresentation of certain groups in genetic databases, based on two recent initiatives.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
Agilent and Genomenon team up to bring users more effective software and search tools for making a genetic diagnosis.